deltatrials
Terminated PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT04327505

Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19 (COVID-19-HBO)

A Randomized, Controlled, Open Label, Multicentre Clinical Trial to Explore Safety and Efficacy of Hyperbaric Oxygen for Preventing ICU Admission, Morbidity and Mortality in Adult Patients With COVID-19

Sponsor: Blekinge County Council Hospital

Conditions ARDS, Human Acute Respiratory Failure COVID-19 Cytokine Storm SARS (Severe Acute Respiratory Syndrome) Sars-CoV2
Interventions Hyperbaric oxygen
Updated 13 times since 2020 Last updated: Jan 5, 2023 Started: Jun 3, 2020 Primary completion: Jun 30, 2022 Completion: Dec 1, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Futility, change of disease due to virus mutations and/or vaccination

Other ARDS, Human trials with similar outcome

Browse all ARDS, Human trials

Listed as NCT04327505, this PHASE2/PHASE3 trial focuses on ARDS, Human and Acute Respiratory Failure and remains terminated or withdrawn. Sponsored by Blekinge County Council Hospital, it has been updated 13 times since 2020, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Jun 2020 · 31 days · monthly snapshot~Jun 2020 – ~Jul 2020 · 30 days · monthly snapshot~Jul 2020 – ~Dec 2020 · 5 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshot~Jun 2021 – ~Sep 2021 · 3 months · monthly snapshot~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Sep 2022 · 9 months · monthly snapshot~Sep 2022 – ~Feb 2023 · 5 months · monthly snapshot~Feb 2023 – ~Jul 2024 · 17 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  3. Feb 2023 — Jul 2024 [monthly]

    Terminated PHASE2_PHASE3

    Status: Recruiting → Terminated

  4. Sep 2022 — Feb 2023 [monthly]

    Recruiting PHASE2_PHASE3

  5. Dec 2021 — Sep 2022 [monthly]

    Recruiting PHASE2_PHASE3

▶ Show 8 earlier versions

  1. Sep 2021 — Dec 2021 [monthly]

    Recruiting PHASE2_PHASE3

  2. Jun 2021 — Sep 2021 [monthly]

    Recruiting PHASE2_PHASE3

  3. Jan 2021 — Jun 2021 [monthly]

    Recruiting PHASE2_PHASE3

  4. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE2_PHASE3

  5. Jul 2020 — Dec 2020 [monthly]

    Recruiting PHASE2_PHASE3

  6. Jun 2020 — Jul 2020 [monthly]

    Recruiting PHASE2_PHASE3

    Status: Not Yet Recruiting → Recruiting

  7. May 2020 — Jun 2020 [monthly]

    Not Yet Recruiting PHASE2_PHASE3

  8. Apr 2020 — May 2020 [monthly]

    Not Yet Recruiting PHASE2_PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Blekinge County Council Hospital
  • JK Biostatistics AB
  • Karolinska Institutet
  • Karolinska Trial Alliance
  • The Swedish Research Council
  • University of California, San Diego
  • University of Regensburg
Data source: Karolinska Institutet

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations